Osteopontin is a tumor autoantigen in prostate cancer patients

Author:                

Publisher: Spandidos Publications

ISSN: 1792-1074

Source: Oncology Letters, Vol.2, Iss.1, 2011-01, pp. : 109-114

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract